| Literature DB >> 28969697 |
Karen Nieuwenhuijsen1, Antonius M C Schoutens2, Monique H W Frings-Dresen3, Judith K Sluiter3.
Abstract
BACKGROUND: Chronic work-related stress is quite prevalent in the working population and is in some cases accompanied by long-term sick leave. These stress complaints highly impact employees and are costly due to lost productivity and medical expenses. A new treatment platform with light therapy plus Pulsed Electro Magnetic Fields (PEMF) in combination with coaching was used to assess whether more positive effects on return to work, stress, work-related fatigue, and quality of life could be induced compared to coaching alone.Entities:
Keywords: Burnout; Fatigue; Light therapy; PEMF; Quality of life; Return to work; Stress; Work-related chronic stress
Mesh:
Year: 2017 PMID: 28969697 PMCID: PMC5625706 DOI: 10.1186/s12889-017-4720-y
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Fig. 1Xentix treatment platform
Demographics: age, gender and percentage of working hours at work at baseline, per group
| Mean(sd) | Percentage (%) | Median (IQR) |
| ||
|---|---|---|---|---|---|
| Age (years) | Intervention ( | 43 (8.0) | 0.01 | ||
| Placebo ( | 47 (9.7) | ||||
| Control ( | 40 (8.9) | ||||
| Gender (% women) | Intervention ( | 72 | 0.87 | ||
| Placebo ( | 69 | ||||
| Control ( | 66 | ||||
| Work-hours RTW at baseline (% of contract hours) | Intervention ( | 7.3 (16.70) | 0.0 (1.25) | 0.17 | |
| Placebo ( | 13.2 (20.44) | 0.0 (24.31) | |||
| Control ( | 6.9 (17.80) | 0.0 (0.00) |
*Independent sample T-test for age, Chi-square test for gender and Kruskal-Wallis for Work-hours RTW
Median (IQR) or mean (sd) scores of primary and secondary outcomes in three groups over time
| Outcomes: | Baseline | Week 6 | Week 12 (after treatment) | Week 24 |
|
| |
|---|---|---|---|---|---|---|---|
| Primary outcome: Median (IQR) | |||||||
| % work-hours RTW (0–100)** | Intervention | 0.0 (1.25) | – | 22.5 (66.67) | 94.7 (80.63) | 0.92 | |
| Placebo | 0.0 (24.31) | – | 14.3 (64.50) | 88.2 (58.54) | |||
| Control | 0.0 (0.00) | – | 25.0 (52.50) | 62.5 (72.31) | |||
| Total group | 0.0 (4.06) | 20.0 (60.56) | 87.5 (70.94) | 0.00 | |||
| Secondary outcomes: | |||||||
| Emotional exhaustion* | Intervention | 4.9 (1.28) | – | 3.2 (1.46) | 0.20 | ||
| Placebo | 5.2 (1.26) | – | 2.6 (1.30) | ||||
| Control | 5.3 (0.89) | – | 3.2 (1.63) | ||||
| Total group | 5.1 (1.16) | 3.0 (1.47) | 0.00 | ||||
| Work-related fatigue(0–100)*Median (IQR) | Intervention | 90.9 (27.27) | 72.7 (50.0) | 40.9 (59.09) | – | 0.70 | |
| Placebo | 90.9 (15.91) | 72.7 (43.18) | 40.9 (52.27) | – | |||
| Control | 90.9 (9.09) | 81.8 (50.0) | 50.0 (68.18) | – | |||
| Total group | 90.9 (25.0) | 81.8 (43.18) | 45.5 (63.6) | 0.00 | |||
| Vitality (QoL) (0–100)** | Intervention | 31.7 (18.82) | 44.3(18.60) | 52.7 (21.32) | – | 0.20 | |
| Placebo | 29.2 (17.80) | 46.6(17.95) | 63.2 (16.40) | – | |||
| Control | 27.8 (13.50) | 40.5(16.26) | 52.1(18.88) | – | |||
| Total group | 29.6 (16.76) | 43.7 (17.59) | 53.0 (19.43) | 0.00 | |||
| Stress (0–64)* | Intervention | 22.0 (7.47) | 16.3(7.43) | 12.0 (7.36) | – | 0.95 | |
| Placebo | 21.9 (8.34) | 14.1(8.20) | 9.4 (7.41) | – | |||
| Control | 23.0 (8.01) | 16.6(9.51) | 13.1 (9.29) | – | |||
| Total group | 22.3 (7.88) | 15.7 (8.40) | 11.5 (8.12) | 0.00 | |||
| Cortisol (pg/mg) | Intervention | 32.2 (38.48) | – | 39.1 (44.38) | – | 0.40 | |
| Placebo | 38.8 (85.58) | – | 30.1 (26.71) | – | |||
| Control | 20.5 (15.44) | – | 30.0 (19.36) | – | |||
| Total group | 29.9 (52.60) | 32.0 (31.09) | 0.00 | ||||
| Emotional role limitation (QoL) (0–100)** | Intervention | 21.1 (28.34) | 35.6 (37.72) | 64.3 (32.62) | – | 0.96 | |
| Placebo | 22.6 (27.74) | 46.4 (39.90) | 67.9 (33.31) | – | |||
| Control | 17.8 (17.78) | 30.0 (36.46) | 58.3 (39.15) | – | |||
| Total group | 20.5 (28.00) | 37.2 (38.18) | 63.5 (34.95) | 0.00 | |||
| Social Functioning (QoL) (0–100)** | Intervention | 44.6 (30.39) | 55.6 (18.78) | 68.8 (22.69) | – | 0.71 | |
| Placebo | 44.4 (23.90) | 62.1 (24.17) | 74.1 (20.67) | – | |||
| Control | 41.7 (22.10) | 49.2 (23.20) | 66.5 (23.20) | – | |||
| Total group | 43.5 (25.44) | 55.5 (22.53) | 69.8 (22.40) | 0.00 | |||
*higher scores reflect worse outcomes
**higher scores reflect better outcomes
***For non-parametric tests, only p-value of the between group difference at the last data point is presented